nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlordiazepoxide—CYP2D6—Parkinson's disease	0.72	1	CbGaD
Chlordiazepoxide—GABRB2—hindbrain—Parkinson's disease	0.0044	0.044	CbGeAlD
Chlordiazepoxide—GABRA2—hindbrain—Parkinson's disease	0.00402	0.0402	CbGeAlD
Chlordiazepoxide—GABRA1—hindbrain—Parkinson's disease	0.00388	0.0389	CbGeAlD
Chlordiazepoxide—GABRA5—forebrain—Parkinson's disease	0.00321	0.0321	CbGeAlD
Chlordiazepoxide—GABRB2—brainstem—Parkinson's disease	0.00252	0.0252	CbGeAlD
Chlordiazepoxide—GABRG2—forebrain—Parkinson's disease	0.00243	0.0244	CbGeAlD
Chlordiazepoxide—GABRB2—forebrain—Parkinson's disease	0.00243	0.0244	CbGeAlD
Chlordiazepoxide—GABRA2—brainstem—Parkinson's disease	0.0023	0.0231	CbGeAlD
Chlordiazepoxide—GABRA1—brainstem—Parkinson's disease	0.00223	0.0223	CbGeAlD
Chlordiazepoxide—GABRA2—forebrain—Parkinson's disease	0.00222	0.0223	CbGeAlD
Chlordiazepoxide—GABRA1—forebrain—Parkinson's disease	0.00215	0.0215	CbGeAlD
Chlordiazepoxide—GABRB3—forebrain—Parkinson's disease	0.00187	0.0187	CbGeAlD
Chlordiazepoxide—GABRA5—head—Parkinson's disease	0.00184	0.0184	CbGeAlD
Chlordiazepoxide—GABRB2—medulla oblongata—Parkinson's disease	0.00176	0.0176	CbGeAlD
Chlordiazepoxide—GABRG2—medulla oblongata—Parkinson's disease	0.00176	0.0176	CbGeAlD
Chlordiazepoxide—GABRA5—nervous system—Parkinson's disease	0.00174	0.0174	CbGeAlD
Chlordiazepoxide—GABRA3—head—Parkinson's disease	0.00171	0.0171	CbGeAlD
Chlordiazepoxide—CYP2D6—hindbrain—Parkinson's disease	0.0017	0.017	CbGeAlD
Chlordiazepoxide—GABRA5—central nervous system—Parkinson's disease	0.00168	0.0168	CbGeAlD
Chlordiazepoxide—GABRA3—nervous system—Parkinson's disease	0.00162	0.0162	CbGeAlD
Chlordiazepoxide—GABRG2—midbrain—Parkinson's disease	0.00161	0.0161	CbGeAlD
Chlordiazepoxide—GABRB2—midbrain—Parkinson's disease	0.00161	0.0161	CbGeAlD
Chlordiazepoxide—GABRG2—spinal cord—Parkinson's disease	0.00157	0.0157	CbGeAlD
Chlordiazepoxide—GABRB2—spinal cord—Parkinson's disease	0.00157	0.0157	CbGeAlD
Chlordiazepoxide—GABRA3—central nervous system—Parkinson's disease	0.00156	0.0156	CbGeAlD
Chlordiazepoxide—GABRA1—medulla oblongata—Parkinson's disease	0.00155	0.0155	CbGeAlD
Chlordiazepoxide—GABRA1—midbrain—Parkinson's disease	0.00142	0.0142	CbGeAlD
Chlordiazepoxide—GABRB2—head—Parkinson's disease	0.00139	0.0139	CbGeAlD
Chlordiazepoxide—GABRG2—head—Parkinson's disease	0.00139	0.0139	CbGeAlD
Chlordiazepoxide—GABRA1—spinal cord—Parkinson's disease	0.00138	0.0139	CbGeAlD
Chlordiazepoxide—GABRB3—medulla oblongata—Parkinson's disease	0.00135	0.0135	CbGeAlD
Chlordiazepoxide—GABRA5—brain—Parkinson's disease	0.00133	0.0133	CbGeAlD
Chlordiazepoxide—GABRB2—nervous system—Parkinson's disease	0.00132	0.0132	CbGeAlD
Chlordiazepoxide—GABRG2—nervous system—Parkinson's disease	0.00132	0.0132	CbGeAlD
Chlordiazepoxide—GABRA2—head—Parkinson's disease	0.00127	0.0127	CbGeAlD
Chlordiazepoxide—GABRB2—central nervous system—Parkinson's disease	0.00127	0.0127	CbGeAlD
Chlordiazepoxide—GABRG2—central nervous system—Parkinson's disease	0.00127	0.0127	CbGeAlD
Chlordiazepoxide—GABRG2—cerebellum—Parkinson's disease	0.00124	0.0124	CbGeAlD
Chlordiazepoxide—GABRB2—cerebellum—Parkinson's disease	0.00124	0.0124	CbGeAlD
Chlordiazepoxide—GABRA3—brain—Parkinson's disease	0.00124	0.0124	CbGeAlD
Chlordiazepoxide—GABRB3—midbrain—Parkinson's disease	0.00123	0.0124	CbGeAlD
Chlordiazepoxide—GABRA1—head—Parkinson's disease	0.00123	0.0123	CbGeAlD
Chlordiazepoxide—GABRA2—nervous system—Parkinson's disease	0.00121	0.0121	CbGeAlD
Chlordiazepoxide—GABRB3—spinal cord—Parkinson's disease	0.0012	0.0121	CbGeAlD
Chlordiazepoxide—GABRA1—nervous system—Parkinson's disease	0.00117	0.0117	CbGeAlD
Chlordiazepoxide—GABRA2—central nervous system—Parkinson's disease	0.00116	0.0116	CbGeAlD
Chlordiazepoxide—GABRA2—cerebellum—Parkinson's disease	0.00114	0.0114	CbGeAlD
Chlordiazepoxide—GABRA1—central nervous system—Parkinson's disease	0.00112	0.0112	CbGeAlD
Chlordiazepoxide—GABRA1—cerebellum—Parkinson's disease	0.0011	0.011	CbGeAlD
Chlordiazepoxide—GABRB3—head—Parkinson's disease	0.00107	0.0107	CbGeAlD
Chlordiazepoxide—GABRB3—nervous system—Parkinson's disease	0.00101	0.0102	CbGeAlD
Chlordiazepoxide—GABRG2—brain—Parkinson's disease	0.00101	0.0101	CbGeAlD
Chlordiazepoxide—GABRB2—brain—Parkinson's disease	0.00101	0.0101	CbGeAlD
Chlordiazepoxide—GABRB3—central nervous system—Parkinson's disease	0.000977	0.00978	CbGeAlD
Chlordiazepoxide—CYP2D6—brainstem—Parkinson's disease	0.000975	0.00976	CbGeAlD
Chlordiazepoxide—GABRB3—cerebellum—Parkinson's disease	0.000955	0.00956	CbGeAlD
Chlordiazepoxide—CYP2D6—forebrain—Parkinson's disease	0.000941	0.00942	CbGeAlD
Chlordiazepoxide—GABRA2—brain—Parkinson's disease	0.000922	0.00923	CbGeAlD
Chlordiazepoxide—GABRA1—brain—Parkinson's disease	0.000891	0.00892	CbGeAlD
Chlordiazepoxide—GABRB3—brain—Parkinson's disease	0.000775	0.00776	CbGeAlD
Chlordiazepoxide—Amoxapine—HTR7—Parkinson's disease	0.000587	0.0494	CrCbGaD
Chlordiazepoxide—Amoxapine—DRD3—Parkinson's disease	0.000551	0.0465	CrCbGaD
Chlordiazepoxide—Amoxapine—DRD1—Parkinson's disease	0.000541	0.0456	CrCbGaD
Chlordiazepoxide—CYP2D6—head—Parkinson's disease	0.000539	0.0054	CbGeAlD
Chlordiazepoxide—CYP3A4—nervous system—Parkinson's disease	0.000519	0.0052	CbGeAlD
Chlordiazepoxide—Amoxapine—SLC6A3—Parkinson's disease	0.000513	0.0432	CrCbGaD
Chlordiazepoxide—CYP2D6—nervous system—Parkinson's disease	0.000511	0.00512	CbGeAlD
Chlordiazepoxide—CYP3A4—central nervous system—Parkinson's disease	0.0005	0.005	CbGeAlD
Chlordiazepoxide—Chlorprothixene—DRD3—Parkinson's disease	0.000494	0.0416	CrCbGaD
Chlordiazepoxide—CYP2D6—central nervous system—Parkinson's disease	0.000492	0.00492	CbGeAlD
Chlordiazepoxide—Chlorprothixene—DRD1—Parkinson's disease	0.000485	0.0408	CrCbGaD
Chlordiazepoxide—CYP2D6—cerebellum—Parkinson's disease	0.000481	0.00481	CbGeAlD
Chlordiazepoxide—Loxapine—HTR7—Parkinson's disease	0.000458	0.0386	CrCbGaD
Chlordiazepoxide—Amoxapine—HTR1A—Parkinson's disease	0.00045	0.0379	CrCbGaD
Chlordiazepoxide—Loxapine—DRD3—Parkinson's disease	0.000431	0.0363	CrCbGaD
Chlordiazepoxide—Loxapine—DRD1—Parkinson's disease	0.000423	0.0356	CrCbGaD
Chlordiazepoxide—Loxapine—SLC6A3—Parkinson's disease	0.000401	0.0338	CrCbGaD
Chlordiazepoxide—CYP2D6—brain—Parkinson's disease	0.000391	0.00391	CbGeAlD
Chlordiazepoxide—Clozapine—HTR7—Parkinson's disease	0.000385	0.0324	CrCbGaD
Chlordiazepoxide—Amoxapine—DRD2—Parkinson's disease	0.000382	0.0321	CrCbGaD
Chlordiazepoxide—Clozapine—DRD3—Parkinson's disease	0.000362	0.0305	CrCbGaD
Chlordiazepoxide—Clozapine—DRD1—Parkinson's disease	0.000355	0.0299	CrCbGaD
Chlordiazepoxide—Loxapine—HTR1A—Parkinson's disease	0.000351	0.0296	CrCbGaD
Chlordiazepoxide—Nitrazepam—CYP2E1—Parkinson's disease	0.000345	0.0291	CrCbGaD
Chlordiazepoxide—Chlorprothixene—DRD2—Parkinson's disease	0.000342	0.0288	CrCbGaD
Chlordiazepoxide—GABRA5—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000314	0.00187	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Neuronal System—SLC18A2—Parkinson's disease	0.000312	0.00186	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000308	0.00183	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.000306	0.00182	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000303	0.0018	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000303	0.0018	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000301	0.00179	CbGpPWpGaD
Chlordiazepoxide—Loxapine—DRD2—Parkinson's disease	0.000298	0.0251	CrCbGaD
Chlordiazepoxide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000297	0.00177	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000296	0.00176	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000296	0.00176	CbGpPWpGaD
Chlordiazepoxide—Amoxapine—HTR2A—Parkinson's disease	0.000295	0.0248	CrCbGaD
Chlordiazepoxide—Clozapine—HTR1A—Parkinson's disease	0.000295	0.0248	CrCbGaD
Chlordiazepoxide—GABRA5—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000295	0.00175	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000293	0.00174	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000292	0.00174	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000289	0.00172	CbGpPWpGaD
Chlordiazepoxide—GABRB3—BDNF signaling pathway—BDNF—Parkinson's disease	0.000288	0.00172	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000288	0.00171	CbGpPWpGaD
Chlordiazepoxide—GABRA1—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.000285	0.0017	CbGpPWpGaD
Chlordiazepoxide—Midazolam—CYP2E1—Parkinson's disease	0.000285	0.024	CrCbGaD
Chlordiazepoxide—GABRA2—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000284	0.00169	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000284	0.00169	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000283	0.00168	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000282	0.00168	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000282	0.00168	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Neuronal System—GRIK2—Parkinson's disease	0.000282	0.00168	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000279	0.00166	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000278	0.00165	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000277	0.00165	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000276	0.00165	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000276	0.00165	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000276	0.00164	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000274	0.00163	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Neuronal System—SLC18A2—Parkinson's disease	0.000273	0.00162	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000272	0.00162	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000271	0.00161	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Neuronal System—CHRNA4—Parkinson's disease	0.00027	0.00161	CbGpPWpGaD
Chlordiazepoxide—Amoxapine—CYP2D6—Parkinson's disease	0.00027	0.0227	CrCbGaD
Chlordiazepoxide—GABRG2—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000267	0.00159	CbGpPWpGaD
Chlordiazepoxide—Chlorprothixene—HTR2A—Parkinson's disease	0.000264	0.0222	CrCbGaD
Chlordiazepoxide—GABRA5—Neuronal System—CHRNA4—Parkinson's disease	0.000262	0.00156	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000258	0.00154	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Neuronal System—CHRNA4—Parkinson's disease	0.000258	0.00153	CbGpPWpGaD
Chlordiazepoxide—GABRB3—BDNF signaling pathway—NGF—Parkinson's disease	0.000256	0.00152	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Neuronal System—CHRNA4—Parkinson's disease	0.000253	0.00151	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Neuronal System—CHRNA4—Parkinson's disease	0.000252	0.0015	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.00025	0.00149	CbGpPWpGaD
Chlordiazepoxide—Clozapine—DRD2—Parkinson's disease	0.00025	0.0211	CrCbGaD
Chlordiazepoxide—GABRB2—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000248	0.00148	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Neuronal System—HSPA8—Parkinson's disease	0.000248	0.00147	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Neuronal System—CHRNA4—Parkinson's disease	0.000247	0.00147	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000247	0.00147	CbGpPWpGaD
Chlordiazepoxide—Diazepam—CYP2E1—Parkinson's disease	0.000244	0.0205	CrCbGaD
Chlordiazepoxide—GABRA1—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000242	0.00144	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000241	0.00144	CbGpPWpGaD
Chlordiazepoxide—Clozapine—CYP2E1—Parkinson's disease	0.000241	0.0203	CrCbGaD
Chlordiazepoxide—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000241	0.00143	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Neuronal System—HSPA8—Parkinson's disease	0.000241	0.00143	CbGpPWpGaD
Chlordiazepoxide—GABRA1—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.00024	0.00143	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.00024	0.00143	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.00024	0.00143	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000239	0.00142	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000237	0.00141	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000237	0.00141	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Neuronal System—HSPA8—Parkinson's disease	0.000236	0.00141	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000235	0.0014	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000234	0.00139	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000233	0.00139	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Neuronal System—DLG4—Parkinson's disease	0.000232	0.00138	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Neuronal System—HSPA8—Parkinson's disease	0.000232	0.00138	CbGpPWpGaD
Chlordiazepoxide—GABRA1—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.000232	0.00138	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000231	0.00138	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000231	0.00138	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000231	0.00138	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Neuronal System—HSPA8—Parkinson's disease	0.000231	0.00137	CbGpPWpGaD
Chlordiazepoxide—Loxapine—HTR2A—Parkinson's disease	0.00023	0.0194	CrCbGaD
Chlordiazepoxide—GABRB3—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.00023	0.00137	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000227	0.00135	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Neuronal System—GRIN2B—Parkinson's disease	0.000227	0.00135	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Neuronal System—HSPA8—Parkinson's disease	0.000226	0.00135	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Neuronal System—DLG4—Parkinson's disease	0.000226	0.00134	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000226	0.00134	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Neuronal System—SLC6A3—Parkinson's disease	0.000224	0.00133	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Neuronal System—DLG4—Parkinson's disease	0.000222	0.00132	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Neuronal System—GRIN2B—Parkinson's disease	0.000221	0.00131	CbGpPWpGaD
Chlordiazepoxide—Clobazam—ABCB1—Parkinson's disease	0.000219	0.0185	CrCbGaD
Chlordiazepoxide—GABRA2—Neuronal System—DLG4—Parkinson's disease	0.000218	0.0013	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Neuronal System—SLC6A3—Parkinson's disease	0.000217	0.00129	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Neuronal System—GRIN2B—Parkinson's disease	0.000217	0.00129	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Neuronal System—DLG4—Parkinson's disease	0.000216	0.00129	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Neuronal System—CHRNA4—Parkinson's disease	0.000216	0.00129	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Neuronal System—SLC6A3—Parkinson's disease	0.000213	0.00127	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Neuronal System—GRIN2B—Parkinson's disease	0.000213	0.00127	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Neuronal System—DLG4—Parkinson's disease	0.000212	0.00126	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000212	0.00126	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Neuronal System—GRIN2B—Parkinson's disease	0.000211	0.00126	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Biological oxidations—GSTA4—Parkinson's disease	0.000211	0.00126	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Neuronal System—SLC6A3—Parkinson's disease	0.00021	0.00125	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000209	0.00125	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Neuronal System—SLC6A3—Parkinson's disease	0.000208	0.00124	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000208	0.00124	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Neuronal System—GRIN2B—Parkinson's disease	0.000208	0.00124	CbGpPWpGaD
Chlordiazepoxide—GABRA1—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000206	0.00123	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Neuronal System—SLC6A3—Parkinson's disease	0.000205	0.00122	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000199	0.00118	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Neuronal System—HSPA8—Parkinson's disease	0.000198	0.00118	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000198	0.00118	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000197	0.00117	CbGpPWpGaD
Chlordiazepoxide—GABRA1—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000196	0.00117	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000194	0.00115	CbGpPWpGaD
Chlordiazepoxide—Clozapine—HTR2A—Parkinson's disease	0.000193	0.0163	CrCbGaD
Chlordiazepoxide—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000191	0.00114	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Neuronal System—COMT—Parkinson's disease	0.00019	0.00113	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Neuronal System—MAOA—Parkinson's disease	0.000189	0.00112	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Biological oxidations—MAOB—Parkinson's disease	0.000188	0.00112	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Neuronal System—DLG4—Parkinson's disease	0.000186	0.00111	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Neuronal System—COMT—Parkinson's disease	0.000185	0.0011	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Neuronal System—MAOA—Parkinson's disease	0.000184	0.00109	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000183	0.00109	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Neuronal System—COMT—Parkinson's disease	0.000182	0.00108	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Neuronal System—GRIN2B—Parkinson's disease	0.000182	0.00108	CbGpPWpGaD
Chlordiazepoxide—Nitrazepam—ABCB1—Parkinson's disease	0.000181	0.0153	CrCbGaD
Chlordiazepoxide—GABRA3—Neuronal System—MAOA—Parkinson's disease	0.00018	0.00107	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Neuronal System—SLC6A3—Parkinson's disease	0.000179	0.00106	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Neuronal System—COMT—Parkinson's disease	0.000178	0.00106	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000178	0.00106	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Neuronal System—COMT—Parkinson's disease	0.000177	0.00105	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Neuronal System—MAOA—Parkinson's disease	0.000177	0.00105	CbGpPWpGaD
Chlordiazepoxide—Clozapine—CYP2D6—Parkinson's disease	0.000177	0.0149	CrCbGaD
Chlordiazepoxide—GABRB3—Neuronal System—MAOA—Parkinson's disease	0.000176	0.00105	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000175	0.00104	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Neuronal System—COMT—Parkinson's disease	0.000174	0.00104	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Neuronal System—MAOA—Parkinson's disease	0.000173	0.00103	CbGpPWpGaD
Chlordiazepoxide—Chlorprothixene—ABCB1—Parkinson's disease	0.000172	0.0145	CrCbGaD
Chlordiazepoxide—GABRA2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000172	0.00102	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000172	0.00102	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000171	0.00102	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000169	0.00101	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000168	0.000999	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000164	0.000976	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000161	0.000959	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000158	0.000942	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000157	0.000936	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000157	0.000936	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000154	0.000919	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Neuronal System—COMT—Parkinson's disease	0.000152	0.000905	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Neuronal System—MAOA—Parkinson's disease	0.000151	0.000899	CbGpPWpGaD
Chlordiazepoxide—Midazolam—ABCB1—Parkinson's disease	0.000149	0.0126	CrCbGaD
Chlordiazepoxide—GABRA1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000147	0.000873	CbGpPWpGaD
Chlordiazepoxide—GABRB3—BDNF signaling pathway—CASP3—Parkinson's disease	0.000144	0.000857	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000138	0.000821	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000136	0.000809	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000135	0.000804	CbGpPWpGaD
Chlordiazepoxide—GABRB3—BDNF signaling pathway—MAPK8—Parkinson's disease	0.000132	0.000788	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000129	0.00077	CbGpPWpGaD
Chlordiazepoxide—Diazepam—ABCB1—Parkinson's disease	0.000128	0.0108	CrCbGaD
Chlordiazepoxide—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	0.000128	0.000761	CbGpPWpGaD
Chlordiazepoxide—Clozapine—ABCB1—Parkinson's disease	0.000126	0.0106	CrCbGaD
Chlordiazepoxide—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000126	0.00075	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000123	0.000732	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.00012	0.000716	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000117	0.000696	CbGpPWpGaD
Chlordiazepoxide—GABRA1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000116	0.000692	CbGpPWpGaD
Chlordiazepoxide—GABRA1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000116	0.00069	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000116	0.000688	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000115	0.000683	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000113	0.000671	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000112	0.000668	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000112	0.000667	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.00011	0.000656	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.00011	0.000655	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000108	0.000645	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000108	0.00064	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Biological oxidations—COMT—Parkinson's disease	0.000106	0.00063	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000106	0.000629	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	0.000105	0.000627	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	0.000105	0.000626	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	0.000104	0.000622	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000104	0.000619	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.0001	0.000598	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	9.76e-05	0.000581	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	9.68e-05	0.000576	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	9.64e-05	0.000574	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	9.62e-05	0.000573	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	9.58e-05	0.00057	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	9.55e-05	0.000568	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	9.42e-05	0.00056	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	9.36e-05	0.000557	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	9.35e-05	0.000557	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	9.24e-05	0.00055	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	9.2e-05	0.000547	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	9.18e-05	0.000547	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	9.13e-05	0.000544	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	9.04e-05	0.000538	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	9.01e-05	0.000536	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	8.98e-05	0.000534	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	8.82e-05	0.000525	CbGpPWpGaD
Chlordiazepoxide—GABRA1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	8.43e-05	0.000502	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	8.35e-05	0.000497	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	8.24e-05	0.00049	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	8.03e-05	0.000478	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	7.71e-05	0.000459	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Biological oxidations—COMT—Parkinson's disease	6.92e-05	0.000412	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	6.89e-05	0.00041	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	6.87e-05	0.000409	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—ND3—Parkinson's disease	6.87e-05	0.000409	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—MCCC1—Parkinson's disease	6.87e-05	0.000409	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	6.83e-05	0.000406	CbGpPWpGaD
Chlordiazepoxide—GABRA1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	6.8e-05	0.000405	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	6.79e-05	0.000404	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—TALDO1—Parkinson's disease	6.46e-05	0.000384	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—OMD—Parkinson's disease	6.46e-05	0.000384	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	6.33e-05	0.000377	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	6.24e-05	0.000372	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	6.12e-05	0.000364	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—GCH1—Parkinson's disease	5.84e-05	0.000347	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—FBP1—Parkinson's disease	5.2e-05	0.00031	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—DBH—Parkinson's disease	5.2e-05	0.00031	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—GBA—Parkinson's disease	5.2e-05	0.00031	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—ND3—Parkinson's disease	4.49e-05	0.000267	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—MCCC1—Parkinson's disease	4.49e-05	0.000267	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—TALDO1—Parkinson's disease	4.22e-05	0.000251	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—OMD—Parkinson's disease	4.22e-05	0.000251	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	4e-05	0.000238	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—DDC—Parkinson's disease	3.82e-05	0.000227	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—GCH1—Parkinson's disease	3.82e-05	0.000227	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—GSTA4—Parkinson's disease	3.61e-05	0.000215	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—GBA—Parkinson's disease	3.4e-05	0.000202	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—FBP1—Parkinson's disease	3.4e-05	0.000202	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—DBH—Parkinson's disease	3.4e-05	0.000202	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	3.25e-05	0.000193	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—MAOB—Parkinson's disease	3.21e-05	0.000191	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—DDC—Parkinson's disease	2.5e-05	0.000149	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—GSTA4—Parkinson's disease	2.36e-05	0.00014	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—CTGF—Parkinson's disease	2.35e-05	0.00014	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	2.19e-05	0.00013	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—NQO1—Parkinson's disease	2.16e-05	0.000129	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—TH—Parkinson's disease	2.13e-05	0.000127	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	2.12e-05	0.000126	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—MAOB—Parkinson's disease	2.1e-05	0.000125	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—CYCS—Parkinson's disease	2.04e-05	0.000122	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—COMT—Parkinson's disease	1.81e-05	0.000108	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.8e-05	0.000107	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.8e-05	0.000107	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.78e-05	0.000106	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.71e-05	0.000102	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.66e-05	9.86e-05	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.59e-05	9.44e-05	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.56e-05	9.3e-05	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.53e-05	9.13e-05	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.46e-05	8.71e-05	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.43e-05	8.5e-05	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.41e-05	8.41e-05	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—TH—Parkinson's disease	1.39e-05	8.29e-05	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—APOE—Parkinson's disease	1.36e-05	8.11e-05	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.34e-05	7.96e-05	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—COMT—Parkinson's disease	1.18e-05	7.05e-05	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.18e-05	7.01e-05	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.18e-05	7e-05	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—INS—Parkinson's disease	1.16e-05	6.93e-05	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.16e-05	6.92e-05	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.12e-05	6.64e-05	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.08e-05	6.44e-05	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.04e-05	6.17e-05	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—MTHFR—Parkinson's disease	9.57e-06	5.7e-05	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—APOE—Parkinson's disease	8.91e-06	5.3e-05	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—INS—Parkinson's disease	7.61e-06	4.53e-05	CbGpPWpGaD
